Description

PPACK TFA is a plasminogen activator (rt-PA) inhibitor. PPACK TFA can inhibit changes in fibrin degradation products, plasminogen and alpha 2-antiplasmin. PPACK TFA also inhibits the binding of rt-PA to plasma protease inhibitors[1].–20°C (Powder, sealed storage, away from moisture)–Neuroscience-Neuromodulation–C23H32ClF3N6O5—-[1]Mohler MA, et al. D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost. 1986;56(2):160-164.–157379-44-7–564.99–99.28–O=C([C@H]1N(CCC1)C([C@H](N)CC2=CC=CC=C2)=O)N[C@@H](CCCNC(N)=N)C(CCl)=O.O=C(C(F)(F)F)O–Cardiovascular Disease–DMSO : 250 mg/mL (ultrasonic)–PAI-1—-Metabolic Enzyme/Protease–Peptides